In Memoriam

Recently published articles about In Memoriam

JCP
In Memoriam: Terence A. Ketter, MD
In Memoriam

In Memoriam: Terence A. Ketter, MD

August 18, 2025

Eminent bipolar disorder researcher and clinician Terence A. Ketter, MD, is remembered.
,
JCP
In Memoriam: Robert M. A. Hirschfeld, MD
In Memoriam

In Memoriam: Robert M. A. Hirschfeld, MD

March 20, 2023

Robert M. A. Hirschfeld is remembered as a pioneer in the phenomenology and treatment of bipolar disorder.
JCP
In Memoriam: Joseph Biederman, MD
In Memoriam

In Memoriam: Joseph Biederman, MD

February 22, 2023

Colleagues and friends remember Joseph Biederman and reflect on his legacy as the father of pediatric psychopharmacology.
, , , et al
JCP
In Memoriam: Charles Bowden, MD, 1938–2022
In Memoriam

In Memoriam: Charles Bowden, MD, 1938–2022

September 5, 2022

Over his long and distinguished career, Charles Bowden, MD, was a tireless advocate for bipolar disorder patients and an inspiration to colleagues. Trisha Suppes and Gary Sachs reflect on...
,
JCP
In Memoriam: Jan Fawcett, MD
In Memoriam

In Memoriam: Jan Fawcett, MD

July 11, 2022

A. John Rush and Steven D. Hollon reflect on Fawcett’s life and his contributions to the field, especially in the areas of treatment-resistant depression and suicide.
,
JCP
In Memoriam

In Memoriam: Aaron T. Beck, MD

January 4, 2022

Aaron T. Beck, founding father of Cognitive Therapy, was ranked the fourth most influential person in the history of medicine in a 2016 survey. Colleague and friend Michael Thase...

Recent JCP Articles on In Memoriam

PCC
Managing 7-hydroxymitragynine Withdrawal
Case Report

Managing 7-hydroxymitragynine Withdrawal

August 27, 2026

A 49-year-old man taking “7-OH” experienced significant opioid withdrawal symptoms that resolved with high-dose buprenorphine-naloxone treatment.
,
JCP
Obstetric Risk Associated with Stimulant vs Nonstimulant Treatment
Original Research

Obstetric Risk Associated with Stimulant vs Nonstimulant Treatment

August 26, 2026

Stimulant and nonstimulant use during pregnancy were both associated with increased risk for obstetric complications vs no medication.
,
JCP
ADHD Medication Safety in Pregnancy: Precise Estimates, Uncertain Causal Inference
Commentary

ADHD Medication Safety in Pregnancy: Precise Estimates, Uncertain Causal Inference

August 26, 2026

Comments on a recent study by Babinski and Tuan finding ADHD medication use predictive of adverse pregnancy outcomes.

Recent PCC Articles on In Memoriam

JCP
The Prescriber’s Guide to Oral Ketamine for Depression
Clinical and Practical Psychopharmacology

The Prescriber’s Guide to Oral Ketamine for Depression

August 26, 2026

Explains clinical contexts in which oral ketamine can be used and presents a detailed protocol for the use of this intervention.
PCC
Generative AI in Mental Health
Rounds in the General Hospital

Generative AI in Mental Health

August 25, 2026

As patients rely more on generative AI to assess and manage symptoms, they may mistake its output for professional advice and be unable to gauge accuracy, quality, or biases.
, , , et al
PCC
Aripiprazole-Induced Hiccups
Case Report

Aripiprazole-Induced Hiccups

August 25, 2026

A 29-year-old man hospitalized for psychotic symptoms in the context of methamphetamine experienced persistent hiccups after starting aripiprazole.
, , , et al

Featured In Memoriam Research

JCP
From Screening to Treatment: Rethinking Suicide Risk with Elizabeth Ballard, PhD
Podcast

From Screening to Treatment: Rethinking Suicide Risk with Elizabeth Ballard, PhD

August 25, 2026

Dr. Elizabeth Ballard discusses suicide risk screening tools, ketamine's rapid antisuicidal effects, sleep biomarkers, and ethics of suicide research.
,
Differentiating Bipolar Spectrum Disorders From Other Psychiatric Disorders With Shared Features
Author Insight

Differentiating Bipolar Spectrum Disorders From Other Psychiatric Disorders With Shared Features

August 21, 2026

Mohamed Soliman, MD, on why bipolar disorder often hides inside familiar symptoms, the four questions that reveal the underlying pattern, and how to choose the right screening tool for...
PCC
Anxiety, Depression, and Substance Use in Schizophrenia
Original Research

Anxiety, Depression, and Substance Use in Schizophrenia

August 20, 2026

Early screening and management of anxiety and depressive symptoms in schizophrenia is crucial, as their presence significantly correlates with illness severity and may shape long-term functional outcomes.
, ,
JCP
In Memoriam

In Memoriam: Frederick K. Goodwin, MD

October 13, 2020

S. Nassir Ghaemi reflects on the life and accomplishments of this founding pioneer of psychopharmacology.
JCP
In Memoriam

Donald F. Klein, MD, DSc: 1928-2019

September 17, 2019

A reflection on the legacy and contributions of Donald F. Klein, a founding member of ASCP and pioneer in the modern era of psychiatry.
,
JCP
In Memoriam

Who Was Lori Altshuler?

March 23, 2016

Read about Lori Altshuler's life and how she effected psychiatry throughout her life.
JCP
In Memoriam

Robert L. Spitzer, MD 1932-2015

February 24, 2016

JCP
In Memoriam

In Memoriam: Andrew C. Leon, PhD, 1951-2012

April 15, 2012

JCP
In Memoriam

In Memoriam: Leon J. Thal, MD, 1944-2007

April 16, 2007

,

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe